7-hydroxymitragynine (7-OH) is a minor alkaloid compound found in the plant Mitragynia speciosa (aka kratom).1 Although it is a minor alkaloid in terms of quantity, 7-OH is very interesting to scientists because of its potency and analgesic effects.
The Chemistry of 7-Hydroxymitragynine
7-OH is the oxidized derivative of mitragynine, the primary alkaloid in kratom.
Studies exploring the total and partial synthesis of 7-OH (and its parent compound mitragynine) reveal some interesting findings regarding the structure-activity relationship (SAR) of their molecular scaffold and its interaction with mu opioid receptors (MOR).2–7 For example, the MOR activity of 7-OH stops when small molecular changes are made to the acrylate and ethyl groups on one of the rings. Also, the demethylation of the aryl methoxy group reduces the potency of 7-OH at the MOR.
The Pharmacology of 7-Hydroxymitragynine
Studies have been done to examine how 7-OH interacts with the human mu opioid receptors (hMORs).4 Combining docking study observations with what is known about the SAR of 7-OH at hMORs, suggests that 7-OH and its structural analogs adopt a distinct binding pose in the receptor pocket. Additional experiments showed that 7-OH had a Ki value of 47 nM and was a partial agonist at hMOR.
In addition, studies have shown that 7-OH acts as a competitive antagonist at the human kappa (hKOR) and delta (hDOR) opioid receptors.4
Data from a 2014 study indicates that 7-OH has sufficient permeability and efflux ratios to pass through the blood-brain barrier via passive diffusion.8
The Applications and Potential of 7-Hydroxymitragynine
Research indicates that the analgesic effects of 7-OH are due to its agonist behavior at hMOR. In mice, 7-OH has a potency at hMOR that is 4- to 5-fold higher than the opioid agonist morphine when administered subcutaneously.9,10 Via the oral route, 7-OH is 10- to 20-fold more potent than morphine (morphine has poor oral bioavailability).11 But because it is only a partial agonist, 7-OH has side effects that are significantly milder than morphine.12
Support Scientific Progress
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.